TriSalus Life Sciences, Inc.
TLSI
$5.22
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -61.00% | 69.00% | -59.88% | -57.52% | 81.69% |
| Total Depreciation and Amortization | 8.33% | 29.33% | 2.17% | 474.07% | -8.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 64.05% | -220.30% | 252.48% | 106.33% | -1,804.78% |
| Change in Net Operating Assets | 31.97% | -426.84% | 29.28% | 17.29% | -375.24% |
| Cash from Operations | 49.93% | -45.32% | -3.47% | -6.49% | -307.41% |
| Capital Expenditure | 5.06% | -93.55% | -842.86% | -82.35% | -249.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -27.90% | 10.36% |
| Cash from Investing | 84.80% | -100.00% | 10.81% | -157.35% | -1.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 82.68% | -2,100.00% |
| Issuance of Common Stock | 20,775.00% | 22,443.75% | 6,196.00% | 304.76% | 300.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | 13.12% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Financing | -85.53% | 305.95% | -60.58% | -99.27% | 908.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -129.71% | 536.99% | -194.94% | -255.50% | 822.87% |
